Reduced E-cadherin expression contributes to the loss of p27 kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas

Carcinogenesis

Volumn 26, Issue 6, 2005, Pages 1021-1034

  Motti, Maria Letizia ^a,e   Califano, Daniela ^b   Baldassarre, Gustavo ^c   Celetti, Angela ^a   Merolla, Francesco ^a   Forzati, Floriana ^a   Napolitano, Maria ^c   Tavernise, Barbara ^d   Fusco, Alfredo ^f   Viglietto, Giuseppe ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^e UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; UVOMORULIN; CADHERIN; CELL CYCLE PROTEIN; CTNNB1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLINE; CYTOSKELETON PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL DENSITY; CELL INTERACTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTACT INHIBITION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; THYROID CARCINOMA; UPREGULATION; ADENOCARCINOMA; BIOSYNTHESIS; CARCINOMA; CELL COMMUNICATION; CELL COUNT; GENE EXPRESSION REGULATION; METABOLISM; PAPILLARY CARCINOMA; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR; TUMOR CELL LINE;

ADENOCARCINOMA, FOLLICULAR; BETA CATENIN; CADHERINS; CARCINOMA; CARCINOMA, PAPILLARY; CELL COMMUNICATION; CELL COUNT; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CONTACT INHIBITION; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; CYTOSKELETAL PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; THYROID NEOPLASMS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS;

EID: 22344451906     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgi050     Document Type: Article

References (57)

1. Fagotto, F. and Gumbiner, B.M. (1996) Cell contact-dependent signaling. Dev. Biol., 180, 445-454.
2. Abercrombie, M. (1979) Contact inhibition and malignancy. Nature, 281, 259-262.
3. Deleu, L., Fuks, F., Spitkovsky, D., Horlein, R., Faisst, S. and Rommelaere, J. (1998) Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Mol. Cell. Biol., 18, 409-419.
4. Dietrich, C., Wallenfang, K., Oesch, F. and Wieser, R. (1997) Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene, 15, 2743-2747.
5. Kato, A., Takahashi, H., Takahashi, Y. and Matsushime, H. (1997) Inactivation of the cyclin D-dependent kinase in the rat fibroblast cell line, 3Y1, induced by contact inhibition. J. Biol. Chem., 272, 8065-8070.
6. Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M. and Koff, A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev., 8, 9-22.
7. Holley, R.W. (1975) Control of growth of mammalian cells in cell culture. Nature, 258, 487-490.
8. Tsukita, S., Itoh, M., Nagafuchi, A., Yonemura, S. and Tsukita, S. (1993) Submembranous junctional plaque proteins include potential tumour suppressor molecules. J. Cell. Biol., 123, 1049-1053.
9. Hirohashi, S. and Kanai, Y. (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci., 94, 575-581.
10. Aoki, J., Umeda, M., Takio, K., Titani, K., Utsumi, H., Sasaki, M. and Inoue, K. (1991) Neural cell adhesion molecule mediates contact-dependent inhibition of growth of near-diploid mouse fibroblast cell line m5S/1 M. J. Cell. Biol., 115, 1751-1761.
11. Takahashi, K. and Suzuki, K. (1996) Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion. Exp. Cell Res., 226, 214-222.
12. Kandikonda, S., Oda, D., Niederman, R. and Sorkin, B.C. (1996) Cadherin-mediated adhesion is required for normal growth regulation of human gingival epithelial cells. Cell. Adhes. Commun., 4, 13-24.
13. Yap, A.S., Brieher, W.M. and Gumbiner, B.M. (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annu. Rev. Cell Dev. Biol., 13, 119-146.
14. Gumbiner, B.M. (2000) Regulation of cadherin adhesive activity. J. Cell. Biol., 148, 399-404.
15. Levenberg, S., Yarden, A., Kam, Z. and Geiger, B. (1999) p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene, 18, 869-876.
16. Caveda, L., Martin-Padura, I., Navarro, P., Breviario, F., Corada, M., Gulino, D., Lampugnani, M.G. and Dejana, E. (1999) Inhibition of cultured cell growth by vascular endothelial cadherin (cadherin-5/VE-cadherin). J. Clin. Invest., 98, 886-893.
17. St Croix, B., Sheehan, C., Rak, J.W., Florenes, V.A., Slingerland, J.M. and Kerbel, R.S. (1998) E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell. Biol., 142, 557-571.
18. Vermeulen, K., Van Bockstaele, D.R. and Berneman, Z.N. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif., 36, 131-149.
19. 1-phase progression. Genes Dev., 13, 1501-1512.
20. 0 state) in fibroblasts. J. Biol. Chem., 271, 18337-18341.
21. kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
22. De Groot, L.J., Kaplan, E.L., McCormick, M. and Strauss, F.H. (1990) Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab., 71, 414-424.
23. Giuffrida, D. and Gharib, H. (2000) Anaplastic thyroid carcinoma: current diagnosis and treatment. Ann. Oncol., 11, 1083-1089.
24. kip1 in the cytoplasm of thyroid tumour cells. J. Clin. Invest., 10, 865-874.
25. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1992) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
26. Esposito, V., Baldi, A., De Luca, A., Groger, A.M., Loda, M., Giordano, G.G., Caputi, M., Baldi, F., Pagano, M. and Giordano, A. (1997) Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res., 57, 3381-3385.
27. Slingerland, J. and Pagano, M. (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol., 183, 10-17.
28. kip1 deregulation in cancer: down-regulation or mislocalization? Cell Cycle, 1, 394-400.
29. Kip1 accumulation during the cell cycle. Science, 271, 1861-1864.
30. Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin proteasome pathway in regulating abundance of the cyclin-dependent inhibitor p27. Science, 269, 682-685.
31. Watabe, M., Nagafuchi, A., Tsukita, S. and Takeichi, M. (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell. Biol., 127, 247-256.
32. Tallini, G., Garcia-Rostan, G., Herrero, A., Zelterman, D., Viale, G., Bosari, S. and Carcangiu, M.L. (1999) Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am. J. Surg. Pathol., 23, 678-685.
33. Fuse, T., Tanikawa, M., Nakanishi, M., Ikeda, K., Tada, T., Inagaki, H., Asai, K., Kato, T. and Yamada, K. (2000) p27Kip1 expression by contact inhibition as a prognostic index of human glioma. J. Neurochem., 74, 1393-1399.
34. Slingerland, J.M., Hengst, L., Pan, C.H., Alexander, D., Stampfer, M.R. and Reed, S.I. (1994) A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells. Mol. Cell. Biol., 14, 3683-3694.
35. Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E., Polyak, K., Tsai, L.H., Broudy, V., Perlmutter, R.M., Kaushansky, K. and Roberts, J.M. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumourigenesis, and female sterility in p27(Kip1)-deficient mice. Cell, 85, 733-744.
36. Kiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C., Hoffman, E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A. and Koff, A. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell, 85, 721-732.
37. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D.Y. and Nakayama, K. (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumours. Cell, 87, 707-720.
38. Hirano, M., Hirano, K., Nishimura, J. and Kanaide, H. (2001) Transcriptional up-regulation of p27(Kip1) during contact-induced growth arrest in vascular endothelial cells. Exp. Cell Res., 271, 356-367.
39. Bringuier, P.P., Umbas, R., Schaafsma, H.E., Karthaus, H.F., Debruyne, F.M. and Schalken, J.A. (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53, 3241-3245.
40. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M. and Abe, O. (1989) Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49, 2128-2133.
41. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl Acad. Sci. USA, 92, 7416-7419.
42. Kanai, Y., Ushijima, S., Hui, A.M., Ochiai, A., Tsuda, H., Sakamoto, M. and Hirohashi, S. (1997) The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer, 71, 355-359.
43. Hirohashi, S. (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am. J. Pathol., 153, 333-339.
44. Becker, K.F., Atkinson, M.J., Reich, U., Becker, I., Nekarda, H., Siewert, J.R. and Hofler, H. (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54, 3845-3852.
45. Berx, G., Cleton-Jansen, A.M., Strumane, K., de Leeuw, W.J., Nollet, F., van Roy, F. and Cornelisse, C. (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 13, 1919-1925.
46. Oda, T., Kanai, Y., Shimoyama, Y., Nagafuchi, A., Tsukita, S. and Hirohashi, S. (1993) Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem. Biophys. Res. Commun., 193, 897-904.
47. Oyama, T., Kanai, Y., Ochiai, A., Akimoto, S., Oda, T., Yanagihara, K., Nagafuchi, A., Tsukita, S., Shibamoto, S., Ito, F., Takeichi, M., Matsuda, H. and Hirohashi, S.A. (1994) Truncated β-catenin disrupts the interaction between E-cadherin and β-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res., 54, 6282-6287.
48. Matsuyoshi, N., Hamaguchi, M., Taniguchi, S., Nagafuchi, A., Tsukita, S. and Takeichi, M. (1992) Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell. Biol., 118, 703-714.
49. Ino, Y., Gotoh, M., Sakamoto, M., Tsukagoshi, K. and Hirohashi, S. (2002) Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc. Natl Acad. Sci. USA, 99, 365-370.
50. Aoki, S., Shimamura, T., Shibata, T., Nakanishi, Y., Moriya, Y., Sato, Y., Kitajima, M., Sakamoto, M. and Hirohashi, S. (2003) Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br. J. Cancer, 88, 726-732.
51. Vleminckx, K., Vakaet, L.Jr, Mareel, M., Fiers, W. and van Roy, F. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
52. Brabant, G., Hoang-Vu, C., Cetin, Y., Dralle, H., Scheumann, G., Molne, J., Hansson, G., Jansson, S., Ericson, L.E. and Nilsson, M. (1993) E-cadherin: a differentiation marker in thyroid malignancies. Cancer Res., 53, 4987-4993.
53. Soares, P., Berx, G., van Roy, F. and Sobrinho-Simoes, M. (1997) E-cadherin gene alterations are rare events in thyroid tumors. Int. J. Cancer, 70, 32-38.
54. Husmark, J., Heldin, N.E. and Nilsson, M. (1999) N-cadherin-mediated adhesion and aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Int. J. Cancer, 83, 692-699.
55. Naito, A., Iwase, H., Kuzushima, T., Nakamura, T. and Kobayashi, S. (2001) Clinical significance of E-cadherin expression in thyroid neoplasms. Cancer Res., 76, 176-180.
56. von Wasielewski, R., Rhein, A., Werner, M., Scheumann, G.F., Dralle, H., Potter, E., Brabant, G. and Georgii, A. (1997) Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Res., 57, 2501-2507.
57. Cerrato, A., Fulciniti, F., Avallone, A., Benincasa, G., Palombini, L. and Grieco, M. (1998) Beta- and gamma-catenin expression in thyroid carcinomas. J. Pathol., 185, 267-272.